agilon health, inc. (NYSE:AGL – Get Free Report) has received a consensus rating of “Hold” from the eighteen analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $4.03.
Several equities research analysts recently commented on the company. Sanford C. Bernstein boosted their price target on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Barclays cut their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Finally, William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th.
Check Out Our Latest Research Report on agilon health
Insider Activity
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. Oak Thistle LLC purchased a new stake in agilon health during the fourth quarter valued at $25,000. Ieq Capital LLC bought a new position in shares of agilon health during the 4th quarter valued at approximately $26,000. Signaturefd LLC grew its stake in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after buying an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of agilon health in the 3rd quarter worth approximately $28,000. Finally, Humankind Investments LLC purchased a new position in agilon health during the fourth quarter worth $30,000.
agilon health Stock Performance
agilon health stock opened at $3.43 on Thursday. The firm’s 50 day simple moving average is $2.71 and its 200-day simple moving average is $3.14. The company has a market cap of $1.41 billion, a P/E ratio of -3.64 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- 3 Monster Growth Stocks to Buy Now
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- Why Invest in High-Yield Dividend Stocks?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- What Are Trending Stocks? Trending Stocks Explained
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.